Formerly Galapagos; develops drugs for immune system diseases.
No change
Greenlight owns 482,746 shares of Lakefront Biotherapeutics, worth about $14 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
482,746
Jun 30
482,746
The numbers
Shares they own
482,746
Value on Jun 30, 2026
$14,472,725
about $14 million
Share of their money
0.4%
less than $1 of every $100 · 41st of 46
Price per share on Jun 30
$29.98
Kind
Shares
Also owned by
No other fund we follow
More about Lakefront Biotherapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.